Results 141 to 148 of about 9,311 (148)

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

New England Journal of Medicine, 2019
Sean J Pittock, Achim Berthele, Kazuo Fujihara   +2 more
exaly  

Eculizumab

Nature Reviews Drug Discovery, 2007
exaly  

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Blood, 2008
Robert A Brodsky, Hubert Schrezenmeier, Peter Hillmen   +2 more
exaly  

Eculizumab for paroxysmal nocturnal haemoglobinuria

Lancet, The, 2009
exaly  

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

Lancet Neurology, The, 2017
James F Howard Jr, Kimiaki Utsugisawa, Michael Benatar   +2 more
exaly  

Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine, 2009
Ralph A Gruppo
exaly  

Eculizumab for Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine, 2009
Andreas Kribben
exaly  

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine, 2013
exaly